These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10866141)

  • 41. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
    Zembowicz A; Hatchett RJ; Jakubowski AM; Gryglewski RJ
    Br J Pharmacol; 1993 Sep; 110(1):151-8. PubMed ID: 7693274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs.
    López GV; Batthyány C; Blanco F; Botti H; Trostchansky A; Migliaro E; Radi R; González M; Cerecetto H; Rubbo H
    Bioorg Med Chem; 2005 Oct; 13(20):5787-96. PubMed ID: 15993614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effects of novel metal-nonoates on the cellular components of the vascular system.
    Monti M; Solito R; Puccetti L; Pasotti L; Roggeri R; Monzani E; Casella L; Morbidelli L
    J Pharmacol Exp Ther; 2014 Dec; 351(3):500-9. PubMed ID: 25238748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial nitric oxide has inhibitory effects on rhythmic contractions in the aortas of sinoaortic deafferented rats.
    Rocha ML; Bendhack LM
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):510-8. PubMed ID: 18030060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and promotion angiogenesis effect of chrysin derivatives coupled to NO donors.
    Peng SM; Zou XQ; Ding HL; Ding YL; Lin YB
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1264-6. PubMed ID: 19167219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relaxation of rabbit corpus cavernosum smooth muscle and aortic vascular endothelium induced by new nitric oxide donor substances of the nitrosyl-ruthenium complex.
    Cerqueira JB; Silva LF; Lopes LG; Moraes ME; Nascimento NR
    Int Braz J Urol; 2008; 34(5):638-45; discussion 645-6. PubMed ID: 18986568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelium-dependent and -independent vasorelaxation induced by CIJ-3-2F, a novel benzyl-furoquinoline with antiarrhythmic action, in rat aorta.
    Chang GJ; Lin TP; Ko YS; Lin MS
    Life Sci; 2010 Jun; 86(23-24):869-79. PubMed ID: 20388521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro relaxation of vascular smooth muscle by atropine: involvement of K+ channels and endothelium.
    Kwan CY; Zhang WB; Kwan TK; Sakai Y
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):1-9. PubMed ID: 12802579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of nitric oxide donors and peroxynitrite on the contractile effect and concentration of norepinephrine.
    Shelkovnikov S; Merlic CA; Gonick HC
    Life Sci; 2004 Apr; 74(23):2919-28. PubMed ID: 15050429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs).
    Lolli ML; Rolando B; Tosco P; Chaurasia S; Di Stilo A; Lazzarato L; Gorassini E; Ferracini R; Oliaro-Bosso S; Fruttero R; Gasco A
    Bioorg Med Chem; 2010 Apr; 18(7):2428-38. PubMed ID: 20299227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic ester prodrugs possessing a diazen-1-ium-1,2-diolate moiety: design, synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
    Abdellatif KR; Dong Y; Chen QH; Chowdhury MA; Knaus EE
    Bioorg Med Chem; 2007 Nov; 15(21):6796-801. PubMed ID: 17764958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
    Li H; Wang K; Wan Q; Chen Y
    Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-imidazole histamine NO-donor H3-antagonists.
    Tosco P; Bertinaria M; Di Stilo A; Cena C; Fruttero R; Gasco A
    Farmaco; 2005; 60(6-7):507-12. PubMed ID: 15927183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells.
    Sodano F; Gazzano E; Rolando B; Marini E; Lazzarato L; Fruttero R; Riganti C; Gasco A
    Bioorg Chem; 2021 Jun; 111():104911. PubMed ID: 33901795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New furoxan derivatives for the treatment of ocular hypertension.
    Blangetti M; Rolando B; Chegaev K; Guglielmo S; Lazzarato L; Durante M; Masini E; Almirante N; Bastia E; Impagnatiello F; Fruttero R; Gasco A
    Bioorg Med Chem Lett; 2017 Feb; 27(3):479-483. PubMed ID: 28027869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta.
    Aguirre-Crespo F; Vergara-Galicia J; Villalobos-Molina R; Javier López-Guerrero J; Navarrete-Vázquez G; Estrada-Soto S
    Life Sci; 2006 Aug; 79(11):1062-8. PubMed ID: 16630635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new class of NO-donor H3-antagonists.
    Tosco P; Bertinaria M; Di Stilo A; Marini E; Rolando B; Sorba G; Fruttero R; Gasco A
    Farmaco; 2004 May; 59(5):359-71. PubMed ID: 15120315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The direct effect of levobupivacaine in isolated rat aorta involves lipoxygenase pathway activation and endothelial nitric oxide release.
    Choi YS; Jeong YS; Ok SH; Shin IW; Lee SH; Park JY; Hwang EM; Hah YS; Sohn JT
    Anesth Analg; 2010 Feb; 110(2):341-9. PubMed ID: 19955508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
    Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
    J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, characterization and antibacterial activity of 2-[1-(5-chloro-2-methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-5-(substituted-phenyl)-[1,3,4]oxadiazoles.
    Rai NP; Narayanaswamy VK; Shashikanth S; Arunachalam PN
    Eur J Med Chem; 2009 Nov; 44(11):4522-7. PubMed ID: 19640616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.